Solixia
| Solixia is an early stage specialty pharmaceutical company developing a radioactive agent for detecting aggressive, recurrent breast cancer. |
Contact Information
Name: Irene Susantio
Email: irene.susantio@solixia.com
Telephone: 408.644.6253
Name: Brian Smith
Email: brian.smith@solixia.com
Telephone: 267.968.1366
Last Modified 1/23/08 2:30 PM
|